Skip to main content
SpringerLink
Log in

Raynaud’s phenomenon in undifferentiated connective tissue disease (UCTD)

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The aim of this study was to ascertain which clinical and immunological factors are associated with Raynaud’s phenomenon (RP) in patients with undifferentiated connective tissue disease (UCTD) and to investigate microvascular involvement. A total of 78 patients were evaluated. They all showed symptoms suggestive of a connective tissue disorder (CTD), but did not fulfil the criteria for any of the defined CTDs. They all had a disease duration of at least 1 year. Nailfold capillaroscopy (NC) was performed using a computerised videomicroscope. We diagnosed RP in 52.5% of our patients. Patients with RP showed a higher occurrence of oesophageal dysmotility (p=0.001) and anti-ribonucleoprotein (RNP) antibodies (p=0.004) than those without RP. The distinguishing capillaroscopic characteristics of UCTD patients with RP were widened and irregularly enlarged loops (75 and 55%, respectively), giant capillaries (35%), and less than two haemorrhages per finger (40%). The combination of features indicative of a ‘slow’ scleroderma pattern was present in 18 of 40 patients with UCTD and RP (p=0.0003). Only 3 of the original 78 patients (3.8%) developed a definite CTD. In none of our patients did we observe avascular areas or changes from the original capillaroscopic pattern during follow-up examination. Our study indicates that patients with UCTD would seem to have a benign form of RP, since they show the absence of cutaneous complications, the existence of a mild microvascular damage and a stable nailfold capillary pattern. Further examinations of these patients will be required in order to confirm our findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. LeRoy EC, Maricq HR, Kahaleh MB (1980) Undifferentiated connective tissue syndromes. Arthritis Rheum 23:341–343

    CAS  PubMed  Google Scholar 

  2. Mosca M, Tavoni A, Neri R, Bencivelli W, Bombardieri S (1998) Undifferentiated connective tissue diseases: the clinical and serological profiles in 91 patients followed for at least 1 year. Lupus 7:95–100

    Article  CAS  PubMed  Google Scholar 

  3. Mosca M, Neri R, Bombardieri S (1999) Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol 17:615–620

    CAS  PubMed  Google Scholar 

  4. Mosca M, Neri R, Bencivelli W, Tavoni A, Bombardieri S (2002) Undifferentiated connective tissue diseases: analysis of 83 patients with a minimum follow-up of 5 years. J Rheumatol 29:2345–2349

    PubMed  Google Scholar 

  5. Danieli MG, Fraticelli P, Salvi A, Gabrielli A, Danieli G (1998) Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. Clin Rheumatol 17:195–201

    CAS  PubMed  Google Scholar 

  6. Danieli MG, Fraticelli P, Franceschini F, Cattaneo R, Farsi A, Passaleva A et al (1999) Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases. Clin Exp Rheumatol 17:585–591

    CAS  PubMed  Google Scholar 

  7. Williams HJ, Alarcon GS, Joks R, Steen VD, Bulpitt K, Clegg DO et al (1999) Early undifferentiated connective tissue disease. VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD. J Rheumatol 26:816–825

    CAS  PubMed  Google Scholar 

  8. Block JA, Sequeira W (2001) Raynaud’s phenomenon. Lancet 357:2042–2048

    Article  CAS  PubMed  Google Scholar 

  9. Maricq HR, Harper FE, Khan MM, Tan EM, LeRoy EC (1983) Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol 1:195–205

    CAS  PubMed  Google Scholar 

  10. Mukerji B, Hardin JG (1993) Undifferentiated, overlapping and mixed connective tissue diseases. Am J Med Sci 305:114–119

    CAS  PubMed  Google Scholar 

  11. Ganczarczyk L, Urowitz MB, Gladman DD (1989) Latent lupus. J Rheumatol 16:475–478

    CAS  PubMed  Google Scholar 

  12. Alarcon GS, Williams GV, Singer JZ, Steen VD, Clegg DO, Paulus HE et al (1991) Early undifferentiated connective tissue disease. I. Early clinical manifestation in a large cohort of patient with undifferentiated connective tissue diseases compared with cohorts of well established connective tissue disease. J Rheumatol 18:1332–1339

    CAS  PubMed  Google Scholar 

  13. Dijkstra S, Nieuwenhuys EJ, Swaak AJ (1999) The prognosis and outcome of patients referred to an outpatient clinic for rheumatic diseases characterized by the presence of antinuclear antibodies (ANA). Scand J Rheumatol 28:33–37

    Article  CAS  PubMed  Google Scholar 

  14. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277

    CAS  PubMed  Google Scholar 

  15. Sharp GC (1987) Diagnostic criteria for the classification of MCTD. In: Kasukawa R, Sharp GC (eds) MCTD and anti-nuclear antibodies. Elsevier, Amsterdam, pp 23–32

  16. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criterion Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590

    PubMed  Google Scholar 

  17. Bohan A, Peter JB (1965) Polymyositis and dermatomyositis. Part I. N Engl J Med 292:344–347

    Google Scholar 

  18. Bohan A, Peter JB (1965) Polymyositis and dermatomyositis. Part II. N Engl J Med 292:403–407

    Google Scholar 

  19. Arnett FC, Edwortly SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324

    CAS  PubMed  Google Scholar 

  20. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM et al (1993) Preliminary criteria for the classification of Sjögren’s syndrome. Arthritis Rheum 36:340–347

    CAS  PubMed  Google Scholar 

  21. Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RH, Machin SJ, Barquinero J et al (1989) The “primary” antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 68:366–374

  22. Brennan P, Silman A, Black C, Bernstein R, Coppock J, Maddison P et al (1993) Validity and reliability of three methods used in the diagnosis of Raynaud’s phenomenon. The UK Scleroderma Study Group. Br J Rheumatol 32:357–361

    CAS  PubMed  Google Scholar 

  23. Andrade LE, Gabriel A Jr, Assad RL, Ferrari AJ, Atra E (1990) Panoramic nailfold capillaroscopy. A new reading method and normal range. Semin Arthritis Rheum 20:21–31

    Article  CAS  PubMed  Google Scholar 

  24. Kabasakal Y, Elvins DM, Ring EFJ, McHugh NJ (1996) Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 55:507–512

    CAS  PubMed  Google Scholar 

  25. Tektonidou M, Kaskani E, Skopouli FN, Moutsopoulos HM (1999) Microvascular abnormalities in Sjögren’s syndrome: nailfold capillaroscopy. Rheumatology 38:826–830

    Article  CAS  PubMed  Google Scholar 

  26. Grassi W, Del Medico P, Izzo F, Cervini C (2001) Microvascular involvement in systemic sclerosis: capillaroscopic findings. Semin Arthritis Rheum 30:397–402

    Article  CAS  PubMed  Google Scholar 

  27. Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160

    CAS  PubMed  Google Scholar 

  28. Furtado RNV, Pucinelli MLC, Cristo VV, Andrade LEC, Sato EI (2002) Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud’s phenomenon in SLE patients. Lupus 11:35–41

    Article  CAS  PubMed  Google Scholar 

  29. Spencer-Green G (1998) Outcomes in primary Raynaud’s phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med 158:595–600

    Article  CAS  PubMed  Google Scholar 

  30. De Angelis R, Del Medico P, Blasetti P, Cervini C (2003) Raynaud’s phenomenon: clinical spectrum of 118 patients. Clin Rheumatol 22:279–284

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Patologia Molecolare e Terapie Innovative, Cattedra di Reumatologia, Università Politecnica delle Marche, Ancona, Italy

    Rossella De Angelis, Angela Cerioni, Patrizia Del Medico & Patrizia Blasetti

  2. Cattedra di Reumatologia, Ospedale ‘Augusto Murri’, via dei Colli 52, 60035, Jesi (AN), Italy

    Rossella De Angelis

Authors
  1. Rossella De Angelis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Angela Cerioni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patrizia Del Medico
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Patrizia Blasetti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rossella De Angelis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Angelis, R., Cerioni, A., Del Medico, P. et al. Raynaud’s phenomenon in undifferentiated connective tissue disease (UCTD). Clin Rheumatol 24, 145–151 (2005). https://doi.org/10.1007/s10067-004-0988-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-004-0988-2

Keywords

Search

Navigation